| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.33 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 0.0004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |